High Intensity Focused Ultrasound Market (By Application: Dermatology, Uterine Fibroids; By End-use: Hospitals, Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

High Intensity Focused Ultrasound Market Size and Growth

The global high intensity focused ultrasound market size was estimated at around USD 1.25 billion in 2023 and it is projected to hit around USD 2.48 billion by 2033, growing at a CAGR of 7.08% from 2024 to 2033.

Key Pointers

• The North America dominated the market with the largest market share of 30% in 2023.
• The Asia Pacific region is estimated to expand the fastest CAGR of 7.76% from 2024 to 2033.
• By Application, the dermatology segment generated the maximum market share of 21% in 2023.
• By Application, the uterine fibroid segment is projected to grow at the fastest CAGR of 7.75% over the forecast period.
• By End-use, the hospital segment contributed the largest market share of 40% share in 2023.

High Intensity Focused Ultrasound Market Overview

High intensity focused ultrasound (HIFU) is an innovative medical technology that utilizes focused ultrasound waves to treat various medical conditions. This non-invasive technique is primarily used for tumor ablation, targeted drug delivery, and cosmetic procedures. The HIFU market has been witnessing significant growth due to its advantages over traditional surgical methods, including reduced recovery times, minimal invasiveness, and precise targeting of affected areas.

High Intensity Focused Ultrasound Market Growth Factors

The growth of the High intensity focused ultrasound (HIFU) market is primarily driven by the rising prevalence of chronic diseases, particularly cancer, which necessitates advanced and effective treatment options. HIFU's non-invasive nature and precision in targeting diseased tissues without affecting surrounding healthy structures make it a preferred choice among both patients and healthcare providers. Additionally, continuous advancements in imaging technologies, such as MRI and ultrasound, have significantly improved the accuracy and outcomes of HIFU treatments, further boosting its adoption. The increasing demand for minimally invasive procedures, coupled with the expanding geriatric population prone to chronic ailments, also contributes to the market's robust growth. Furthermore, heightened awareness about the benefits of HIFU and supportive government initiatives aimed at modernizing healthcare systems are expected to propel market expansion in the coming years.

High Intensity Focused Ultrasound Market Trends

• Rising Adoption in Oncology: Increasing use of HIFU for the treatment of various cancers, such as prostate, liver, and pancreatic cancer, due to its effectiveness and precision in targeting tumors.
• Growing Preference for Non-Invasive Procedures: A significant shift towards non-invasive and minimally invasive treatments among patients and healthcare providers is bolstering the demand for HIFU.
• Expansion in Cosmetic Applications: Increased use of HIFU in aesthetic medicine for procedures like skin tightening and body contouring is broadening the market scope.
• Increasing Research and Development: Ongoing research and development activities aimed at expanding the therapeutic applications of HIFU are expected to open new avenues for market growth.

What are the Key Challenges Faced by High Intensity Focused Ultrasound Market?

• Limited Awareness: A lack of awareness among patients and some healthcare providers about the benefits and applications of HIFU can hinder its widespread adoption.
• Availability of Alternative Treatments: The presence of well-established alternative treatment options, such as surgery, radiation therapy, and chemotherapy, can limit the adoption of HIFU.
• Technical Expertise: The need for highly trained personnel to operate HIFU equipment and interpret imaging results poses a challenge, as there may be a shortage of skilled professionals in some regions.
• Reimbursement Issues: Inconsistent or lack of reimbursement policies for HIFU procedures in certain countries can deter patients from opting for this treatment, impacting market growth.
• Variable Clinical Outcomes: While HIFU shows promise in many applications, inconsistent clinical outcomes and limited long-term data for some conditions can affect its credibility and acceptance.

What is the Contribution of North America to High Intensity Focused Ultrasound Market?

The North America High Intensity Focused Ultrasound (HIFU) market accounted for the largest global revenue share of 30% in 2023. This is due to the presence of key market players and ongoing research and development activities in the region. Additionally, the high prevalence of chronic diseases, including cancer, increases demand for effective and less invasive treatments like HIFU.

U.S. High Intensity Focused Ultrasound Market Size 2024 to 2033

The U.S. high intensity focused ultrasound market was estimated at USD 0.26 billion in 2023 and it is expected to surpass around USD 0.52 billion by 2033, poised to grow at a CAGR of 7.17% from 2024 to 2033.

In the U.S., the HIFU market held the largest share in the North America region in 2023. The rising prevalence of various cancers, such as prostate and breast cancer, is expected to boost the adoption of HIFU as a less-invasive alternative to surgery. According to the International Agency for Research on Cancer, there were approximately 230,125 prostate cancer cases in the U.S. in 2022, with 33,746 reported deaths.

The Asia Pacific High Intensity Focused Ultrasound (HIFU) market is projected to experience the fastest CAGR of 7.76% during the forecast period. Advancements in healthcare infrastructure and increasing healthcare expenditures in countries like China, Japan, and South Korea are driving the adoption of innovative medical technologies, including HIFU. Additionally, the region's growing aging population, alongside evolving healthcare policies and favorable regulatory frameworks, is supporting the expansion of HIFU applications in both therapeutic and cosmetic fields.

Application Insights

The dermatology segment led the market with a 21% share in 2023, largely due to the increasing use of HIFU technology in aesthetic and therapeutic applications. HIFU is popular in dermatology for non-invasive skin tightening, wrinkle reduction, and facial rejuvenation treatments. This minimally invasive cosmetic solution is favored for its ability to stimulate collagen production and tighten skin without surgery. The American Board of Cosmetic Surgery notes that HIFU treatments for skin tightening yield favorable results within 2–3 months, with proper skin care practices extending these results up to a year.

The uterine fibroid segment is projected to grow at the fastest CAGR of 7.75% over the forecast period. Uterine fibroids, common among women, cause symptoms like heavy menstrual bleeding, pelvic pain, and reproductive issues. HIFU offers a less-invasive alternative to traditional surgeries like hysterectomy or myomectomy, appealing to patients seeking shorter recovery times and fewer complications. Advances in HIFU devices have improved their precision and effectiveness, enhancing safety and efficacy in targeting fibroids while minimizing damage to surrounding tissues. Increased awareness and adoption of non-surgical treatment options, such as HIFU for uterine fibroids, are driving market growth. For example, in June 2024, Nordica Fibroid Care Centre plans to introduce the first HIFU machine for treating uterine fibroids in the nation, following their initial introduction of the HIFU treatment method in Lagos in 2021.

End-use Insights

The hospital segment dominated the market with over 40% share in 2023 and is expected to grow at the fastest CAGR over the forecast period. This is due to hospitals adopting technologically advanced medical devices. For instance, in February 2022, Children’s National Hospital in Washington, D.C., performed the first HIFU surgery on a pediatric patient with neurofibromatosis (NF). Hospitals often have specialized departments and trained medical personnel for effective HIFU treatment administration. Additionally, hospitals treat a wide range of medical conditions, including cancer, where HIFU is beneficial.

The imaging centers segment also held a significant market share in 2023. Equipped with advanced diagnostic technologies essential for guiding and monitoring HIFU procedures, imaging centers are crucial for providing comprehensive diagnostic services. They are increasingly integrating HIFU for minimally invasive treatments and often collaborate with hospitals and healthcare providers to enhance their capacity to deliver specialized care.

Who are the Top Manufactures in High Intensity Focused Ultrasound Market?

• Focal One
• Sonablate Corp.
• Verasonics, Inc.
• ALPINION MEDICAL SYSTEMS Co., Ltd.
• Theraclion
• Chongqing Haifu Medical Technology Co., Ltd.
• Lynton Lasers Ltd
• ULTRAISER
• Profound Medical Inc.

Recent Developments

• In January 2024, Kokilaben Dhirubhai Ambani Hospital in India introduced advanced High-Intensity Focused Ultrasound (HIFU) technology for prostate cancer treatment. This technology uses high-frequency sound waves to precisely target and destroy prostate cancer cells, offering a minimally invasive and highly targeted approach for treating localized prostate cancer.
• In October 2023, the FDA approved HistoSonics' innovative therapy platform, Edison, for treating liver tumors. This approval marks the ninth clinical use of focused ultrasound treatment approved by the FDA. Edison uses histotripsy to noninvasively destroy liver tissue and is the first and only platform of its kind available in the US. This approval also represents the first global regulatory approval for histotripsy.
• In July 2023, EDAP TMS SA, a leading company in robotic energy-based therapies, announced that Switzerland approved reimbursement for High-Intensity Focused Ultrasound (HIFU) to treat prostate cancer, effective July 1, 2023.
• In November 2020, the FDA approved Profound Medical Inc.'s Sonalleve MR-guided high-intensity focused ultrasound (MR-HIFU) system for treating osteoid osteoma in the extremities. This technique combines high-intensity focused ultrasound ablation with real-time temperature monitoring during treatment.

High Intensity Focused Ultrasound Market Segmentation:

By Application

• Uterine Fibroids
• Prostate Cancer
• Essential Tremor
• Dermatology
• Breast Cancer
• Glaucoma
• Backpain, Facetogenic
• Other Applications

By End-use

• Hospitals
• Imaging Centers
• Other End Users         

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa